Molecular Characterization and Prognostication of Large Cell Neuroendocrine Carcinoma and Large Cell Carcinoma.

Front Oncol · 2021 · PMC8796852 · PMID 35096557

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Within the LCNEC subgroup, BRAF mutations (p=0.34, Figure 3C ), but not RB1 mutations (p=0.56, Figure 3D ), still showed a trend of increased survival.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.